Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. 2024-05-01 Health moderate FDA
Health · FDA · Recall #FDA-D-0466-2024
Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka… Recall
Issued May 1, 2024 · Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
In May 2024, Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalled the Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Cross Contamination with Other Products
What you should do
- 1 Stop using Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- Category
- Health
- Recall date
- May 1, 2024
- Units affected
- Not reported
- Sold at
- USA nationwide.
- Recall number
- FDA-D-0466-2024
- Made in
- Japan
- Issuing agency
- FDA
In context
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. has 3 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.